2. Placebo.

3 trials

Sponsors

VU University Medical Center, Amsterdam The Netherlands, Utrecht University Faculty of Science Department of Psychopharmacology, Maastricht University

Conditions

ADHD, atomoxetine, electroencephalography (EEG), event-related potential (ERP), attention, inhibitionSedation / sedatie Antihistamines / antihistaminicaType 2 diabetes mellitus, impaired glucose metabolism

Unknown Phase

PRESERVE TRIAL: Pancreatic beta-cell dysfunction REStorEd by Rosiglitazone and Valsartan Effects. A 52-week randomized controlled factorial study in subjects with IFG and/or IGT. Amendment 2007: PancREatic beta-cell dySfunction rEstoRed by Valsartan Effects – PRESERVE Study. Amendment 2007: In stead of two medicaments (Rosiglitazon and valsartan), only valsartan has been completed. Due to negative publicity, Rosiglitazon was stopped. Target number of participant is thereby decreased from 144

Active, not recruitingNL-OMON23620

VU University Medical Center, Amsterdam The NetherlandsType 2 diabetes mellitus, impaired glucose metabolism

Start: 2006-10-01Target: 80Updated: 2024-02-28

The effects of morning versus evening dose of an antihistamine on cognition.

RecruitingNL-OMON26397

Maastricht UniversitySedation / sedatie Antihistamines / antihistaminica

Start: 2009-06-04Target: 18Updated: 2024-02-28

The effects of atomoxetine on brain potentials in response to auditory distracting sounds during driving in adults with attention-deficit hyperactivity disorder.

RecruitingNL-OMON24935

Utrecht University Faculty of Science Department of PsychopharmacologyADHD, atomoxetine, electroencephalography (EEG), event-related potential (ERP), attention, inhibition

Start: 2009-09-01Target: 30Updated: 2024-02-28